Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Medistim ASA ( (DE:MD1) ) has shared an update.
Medistim ASA has transferred 10,000 shares to CEO Kari Krogstad’s company, K2 Consulting, under an agreement with a three-year lock-up period, qualifying for a 25% discount. The transaction, financed by a company loan, increases Krogstad’s total control to 80,583 shares, while Medistim retains 83,117 own shares.
More about Medistim ASA
Average Trading Volume: 22,791
Current Market Cap: NOK3.72B
For detailed information about MD1 stock, go to TipRanks’ Stock Analysis page.